Effect of depression, anxiety, and stress symptoms on response to cognitive behavioral therapy for insomnia in patients with comorbid insomnia and sleep apnea: a randomized controlled trial
Author(s) -
Alexander Sweetman,
Leon Lack,
R. Doug McEvoy,
Peter Catcheside,
Nick A. Antic,
Ching Li ChaiCoetzer,
James Douglas,
Amanda O’Grady,
Nicola Dunn,
Jan Robinson,
Denzil Paul,
Simon S. Smith
Publication year - 2020
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.8944
Subject(s) - insomnia , anxiety , medicine , randomized controlled trial , depression (economics) , cognitive behavioral therapy for insomnia , sleep apnea , physical therapy , cognitive behavioral therapy , psychiatry , economics , macroeconomics
Patients with comorbid insomnia and sleep apnea (COMISA) report increased severity of depression, anxiety, and stress symptoms compared to patients with either insomnia or sleep apnea alone. Although cognitive behavioral therapy for insomnia (CBTi) is an effective treatment for COMISA, previous research suggests a reduced response to CBTi by patients with insomnia and depression, anxiety, and stress symptoms. Therefore, we used randomized controlled trial data to investigate the impact of depression, anxiety, and stress symptoms before treatment on changes in insomnia after CBTi vs control in patients with COMISA.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom